TCRX - TScan Therapeutics, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-54.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-785%)	286.0% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3475%)	139.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1642%)	473.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5824%)	283.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3445%)	-90.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1235%)	-73.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1013%)	-83.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1137%)	-91.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1246%)	133.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1562%)	15.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+95%)	-22.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-380%)	125.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1465%)	8.4% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6%)	39.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+393%)	42.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+430%)	49.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+513%)	259.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3137%)	731.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9047%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	15.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	40.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-12.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	18.8% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-172.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-4.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	45.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	65.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	85.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	19.0% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	N/M	16.2% Good Good Year-over-year change in earnings per share Optimal: > 10%	91.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	16.0% Good ↑ Good Improving Year-over-year change in net income	35.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-19.5% Weak ↑ Weak Improving Year-over-year change in net income	-16.7% Weak ↑ Weak Improving Year-over-year change in net income	-13.2% Weak ↑ Weak Improving Year-over-year change in net income	-82.6% Weak ↓ Weak Declining Year-over-year change in net income	-30.0% Weak ↓ Weak Declining Year-over-year change in net income	-31.7% Weak ↓ Weak Declining Year-over-year change in net income	-33.6% Weak → Weak Stable Year-over-year change in net income	-4.8% Weak ↑ Weak Improving Year-over-year change in net income	-41.6% Weak → Weak Stable Year-over-year change in net income	-59.3% Weak ↓ Weak Declining Year-over-year change in net income	-39.7% Weak ↓ Weak Declining Year-over-year change in net income	-31.9% Weak ↑ Weak Improving Year-over-year change in net income	-2.6% Weak ↑ Weak Improving Year-over-year change in net income	-41.4% Weak ↑ Weak Improving Year-over-year change in net income	-104.2% Weak ↓ Weak Declining Year-over-year change in net income	-81.9% Weak ↑ Weak Improving Year-over-year change in net income	-120.9% Weak Weak Year-over-year change in net income	-90.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	37.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	-5.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	-11.5% Weak Weak Year-over-year change in free cash flow	4.5% Caution Caution Year-over-year change in free cash flow	—	N/M	49.8% Excellent Excellent Year-over-year change in free cash flow	68.7% Excellent Excellent Year-over-year change in free cash flow	—	—	25.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	94.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-47.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-6.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-9.3% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-8.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-10.4% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-38.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-24.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-42.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-34.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	108.5% Excellent Excellent Compound annual revenue growth over 3 years	137.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-13.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	26.4% Excellent Excellent Compound annual revenue growth over 5 years	54.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	-296.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2074%)	—	—	-334.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2329%)	—	-493.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3386%)	-375.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2606%)	—	-497.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3417%)	—	-375.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2600%)	-390.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2704%)	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	-272.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2367%)	—	—	-331.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2864%)	—	-483.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4125%)	-372.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3202%)	—	-497.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4246%)	—	-374.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3223%)	-390.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3353%)	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	-336.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	169.7% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	-359.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-376.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.40x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.24x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.01x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.28x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.63x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-17.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	14.1% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	14.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	16.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	16.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-14.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-13.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-13.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-9.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-15.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-29.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-297%)	-18.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-224%)	-24.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-20.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-16.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-14.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-13.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-12.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-24.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-13.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-13.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-12.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-28.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-293%)	-18.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-11.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-11.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-8.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-9.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	17.8% Good → Good Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+19%)	15.8% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+6%)	18.4% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+23%)	20.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+37%)	20.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+35%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.34x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-44%)	0.26x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-56%)	0.23x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-62%)	0.18x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	0.13x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-78%)	—	—	0.25x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-59%)	0.18x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	—	—	0.38x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-37%)	0.29x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-51%)	0.25x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-58%)	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-42.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-33.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-53.01x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-56.10x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-53.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-46.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-34.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-35.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-32.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.07x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-25.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-23.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.13x Weak Weak Operating income divided by interest expense Optimal: > 5x	-82.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-95.40M	$-119.87M	$-137.09M	$-137.10M	$-121.93M	$-146.62M	$-133.12M	$-242.16M	$-110.27M	$-106.66M	$-155.19M	$-208.84M	$-66.10M	$-90.74M	$-108.23M	$-125.60M	$-140.84M	$-161.41M	$-182.31M	$-106.20M	$-121.50M	$-34.79M	—	—	—	—
Debt / EBITDA (x)	-1.15x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.41x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.89x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.85x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.90x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.89x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-1.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-1.39x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.71x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.75x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.01	—	$0.02	$0.02	$0.02	—	$0.01	$0.00	$0.01	—	$0.04	$0.07	$0.28	—	$0.14	$0.17	—	—	$0.12	$2.05	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.22	$-0.18	$-0.28	$-0.28	$-0.26	$-0.30	$-0.25	$-0.28	$-0.32	$-0.11	$-0.24	$-0.51	$-0.93	$-0.77	$-0.67	$-0.63	—	$0.38	$-0.80	$-7.69	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.19	—	$-0.26	$-0.27	$-0.30	—	$-0.25	$-0.24	$-0.32	—	$0.07	$-0.48	$-1.01	—	—	$-0.63	—	—	$-0.73	$-10.53	—	—	—	—	—	—
Book Value per Share (USD)	$0.75	—	$1.11	$1.36	$1.62	—	$1.93	$2.25	$1.30	—	$1.78	$4.04	$3.22	—	$4.85	$5.47	—	—	$8.76	$-43.25	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.75	—	$1.11	$1.36	$1.62	—	$1.93	$2.25	$1.30	—	$1.78	$4.04	$3.22	—	$4.85	$5.47	—	—	$8.76	$-43.25	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	129.91M	—	129.84M	129.73M	129.68M	—	118.70M	113.43M	94.88M	—	94.83M	47.21M	24.23M	—	24.07M	24.06M	—	—	19.88M	1.39M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$112.80M	$138.51M	$158.96M	$189.81M	$225.02M	$256.77M	—	—	$133.24M	$164.42M	—	—	$86.86M	$106.82M	$124.58M	—	$127.28M	$144.31M	—	—	—	$19.00M	—	—	—	—
LT Debt (USD)	$32.65M	$32.53M	$32.41M	$32.30M	$32.18M	$32.07M	—	—	$30.25M	$26.70M	—	—	$29.50M	$29.29M	$29.07M	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$96.92M	$123.12M	$144.02M	$176.71M	$210.20M	$240.97M	$229.09M	$255.22M	$122.97M	$150.87M	$168.96M	$190.61M	$78.02M	$99.43M	$116.66M	$131.65M	$145.69M	$160.78M	$174.07M	$-60.03M	$-49.92M	$-42.46M	$-34.84M	$-27.80M	$-22.34M	$-17.14M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$982.00K	$2.57M	$2.51M	$3.08M	$2.17M	$665.00K	$1.05M	$536.00K	$566.00K	$7.21M	$3.89M	$3.15M	$6.80M	$3.10M	$3.36M	$4.06M	$3.02M	$2.85M	$2.41M	$2.85M	$2.03M	$795.00K	$290.00K	—	—	—
Depreciation Expense (USD)	$693.00K	$723.00K	$767.00K	$698.00K	$678.00K	$711.00K	$1.03M	$1.12M	$1.25M	$1.28M	$1.29M	$1.30M	$1.50M	$1.48M	—	$1.21M	$1.20M	$1.14M	$1.06M	$661.00K	$469.00K	$396.00K	$346.00K	—	—	—
Net Income, GAAP (USD)	$-28.67M	$-22.98M	$-35.71M	$-36.95M	$-34.13M	$-35.81M	$-29.89M	$-31.66M	$-30.14M	$-19.61M	$-23.00M	$-24.05M	$-22.56M	$-18.72M	$-16.25M	$-15.10M	$-16.16M	$-14.20M	$-15.84M	$-10.67M	$-7.91M	$-7.81M	$-7.17M	$-5.61M	—	—
Operating Cash Flow (USD)	$-24.28M	$-32.00M	$-32.46M	$-33.27M	$-37.59M	$-27.41M	$-27.92M	$-26.23M	$-29.27M	$-23.77M	$8.02M	$-22.02M	$-23.59M	$-16.01M	—	$-13.37M	$-20.12M	$-14.38M	$-13.64M	$-10.70M	$-9.96M	$-7.35M	$-5.79M	—	—	—

TScan Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TCRX with peers